Results 181 to 190 of about 12,384,515 (284)

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

UK Healthcare Workers' Experiences of Major System Change in Elective Surgery During the COVID-19 Pandemic: Reflections on Rapid Service Adaptation. [PDF]

open access: yesInt J Health Policy Manag, 2022
Singleton G   +10 more
europepmc   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Highly Sensitized Kidney Transplant Outcomes After the 2014 Kidney Allocation System Change. [PDF]

open access: yesProg Transplant
Chang JH   +9 more
europepmc   +1 more source

Implementing major system change in specialist cancer surgery: The role of provider networks. [PDF]

open access: yesJ Health Serv Res Policy, 2021
Vindrola-Padros C   +14 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Evaluating Competence by Design as a Large System Change Initiative: Readiness, Fidelity, and Outcomes. [PDF]

open access: yesPerspect Med Educ
Hall AK   +11 more
europepmc   +1 more source

Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis. [PDF]

open access: yesAppl Health Econ Health Policy, 2022
Clarke CS   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy